Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercator MedicalWAR:MRC +1.18%64 5-Year Yield-on-Cost % is 3.22 as of Jul. 24, 2026, which is 437% above its 10-year median of 0.60. GuruFocus rates WAR:MRC with a GF Score™ of 64/100 and a GF Value™ of zł51.91 (Fairly Valued). The stock has 2 warning signs investors should review. Among 324 Medical Devices & Instruments companies, Mercator Medical ranks better than 57.72% on this metric.
Mercator Medical's yield on cost for the quarter that ended in Mar. 2026 was 3.22.
The historical rank and industry rank for Mercator Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
WAR:MRC'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0 Med: 0.6 Max: 3.22
Current: 3.22
During the past 13 years, Mercator Medical's highest Yield on Cost was 3.22. The lowest was 0.00. And the median was 0.60.
WAR:MRC's 5-Year Yield-on-Cost % is ranked better than 57.72% of 324
companies
in the Medical Devices & Instruments industry
Industry Median: 2.515
vs WAR:MRC: 3.22
Mercator Medical (WAR:MRC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Mercator Medical 5-Year Yield-on-Cost % Related Terms
WAR:MRC vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Mercator Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Mercator Medical's 5-Year Yield-on-Cost % falls into.
Mercator Medical 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Mercator Medical (WAR:MRC) has a 5-Year Yield-on-Cost % of 3.22 as of Jul. 24, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mercator Medical and its competitors. This is 437% above median its historical median of 0.60. According to the industry distribution chart, Mercator Medical ranks #137 out of 324 companies in the Medical Devices & Instruments industry, placing it in the top 42.3%.
Is Mercator Medical's 5-Year Yield-on-Cost % too high?
Mercator Medical's current 5-Year Yield-on-Cost % of 3.22 is 437% above median its 10-year median of 0.60. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.52. Mercator Medical's value of 3.22 is 28% above this industry median. Based on the distribution chart, Mercator Medical ranks #137 out of 324 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mercator Medical has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #137 out of 324 companies for 5-Year Yield-on-Cost %. This puts Mercator Medical in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.52. Mercator Medical's value of 3.22 is 28% above this benchmark. While the company's 10-year median is 0.60 vs. the industry median of 2.52, Mercator Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.52, based on 324 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current 5-Year Yield-on-Cost % of 3.22 is 28% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current 5-Year Yield-on-Cost % is 3.22, which is 437% above median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (WAR:MRC) is currently considered Fairly Valued. The stock's GF Value™ is zł51.91, compared to a current price of zł51.60 — trading 0.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.22, which is 437% above median its 10-year median of 0.60 and 28% above the Medical Devices & Instruments industry median of 2.52. Mercator Medical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Mercator Medical (WAR:MRC), the current 5-Year Yield-on-Cost % is 3.22 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (WAR:MRC) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued.
The current stock price of zł51.60 is trading 0.6% below its estimated GF Value™ of zł51.91.
GuruFocus considers Mercator Medical to be Fairly Valued.
Key valuation signals for WAR:MRC:
5-Year Yield-on-Cost %: 3.22 (437% above median its 10-year median of 0.60)
GF Value™: zł51.91 vs. price of zł51.60 (0.6% below fair value)
Industry Position: 28% above the Medical Devices & Instruments median (#137 of 324)
No single metric tells the full story. See the WAR:MRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
64GF Score
Get the complete analysis for WAR:MRC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MRC has been successfully added to your 
